Search Results 1891-1900 of 26166 for stem cell
Relapsed or refractory disease after allogeneic transplant provided AUTO1 infusion occurs at least 3 months after stem cell transplant. Patients with ...
... Stem Cell Transplant (HSCT). Thromb Res. 2018 Jul; 167:44-49 Epub 2018 Apr 26. View PubMed; Kaur D, Khan SP, Rodriguez V, Arndt C, Claus P. Hyperbaric oxygen ...
... cell lymphoma (DLBCL) that has come back or did not respond to previous treatment in patients who cannot receive a stem cell transplant. This medicine is ...
The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and help develop ...
Solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients are at increased risk for invasive fungal infections. Mortality rates ...
... stem cell transplant. A Study to Evaluate the Safety and Effectiveness of Idecabtagene Vicleucel to Treat Multiple Myeloma. Jacksonville, Fla., Rochester ...
Pierre Noel, M.D.. Internist; Hematologist. Phoenix, AZ. Areas of focus: Bone marrow transplant, Allogeneic stem cell transplant, Autologous stem cell ...
Completion of autologous stem cell transplant within 100 days prior to Cycle 1, Day 1; Prior allogeneic stem cell transplant; History of severe allergic or ...
As her recovery continued, however, Kristen developed acute graft versus host disease, in which the body sees the donor stem cells as something foreign and ...
For example, some researchers think that if a person's diabetes can be cured by a future treatment such as pancreas islet cell transplant or stem cell therapy, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.